NG004 in Spinal Cord Injury Patients

PHASE1RecruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 18, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Acute Spinal Cord Injury (SCI)Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemSpinal Cord Injuries (SCI)Wounds and Injuries
Interventions
DRUG

NG004

repeated intrathecal injections of NG004

Trial Locations (6)

Unknown

RECRUITING

Klinik für Querschnittgelähmte, Klinikum Bayreuth, Bayreuth

NOT_YET_RECRUITING

Zentrum für Rückenmarkverletzte und Klinik für Orthopädie, BG Klinikum Bergmannstrost, Halle

RECRUITING

Klinik für Paraplegiologie, Universitätsklinikum Heidelberg, Heidelberg

RECRUITING

Zentrum für Rückenmarksverletzte, Unfallklinik Murnau, Murnau am Staffelsee

RECRUITING

Swiss Paraplegic Centre, Nottwil

RECRUITING

Universitätsklinik Balgrist, Zurich

Sponsors
All Listed Sponsors
lead

NovaGo Therapeutics AG

INDUSTRY

NCT06817577 - NG004 in Spinal Cord Injury Patients | Biotech Hunter | Biotech Hunter